Latest News
Harrow, Inc.
- The Slantwise Histories by Alix E. Harrow: Review by Gary K. Wolfe
- Harrow (2018)
- Do Options Traders Know Something About Harrow Stock We Don't?
- Harrow: Q3 Needs To Prove The Turnaround Is Real (NASDAQ:HROW)
- Harrow Closes Acquisition of Tyrvaya from Viatris
- Harrow Closes Acquisition of Tyrvaya, a Dry Eye Disease Treatment From Viatris Inc.
- Harrow completes $30M acquisition of TYRVAYA nasal spray
- Harrow invests $30 million in new pharmaceutical as it builds portfolio
- Harrow Closes Acquisition of TYRVAYA®
- Harrow On The Hill - Picture gallery 20
- ‘I can’t get my dog back’: Harrow woman speaks after fatal dog attack
- Elmer’s Manufacturing unveils 130-foot Super 7 harrow
Headlines from the last 30 days, linking to the original publishers. See all market news →